2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

IJMS, Free Full-Text

Frontiers Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly

Personalized Medical Treatment of Patients With Acromegaly: A Review - ScienceDirect

IJMS, Free Full-Text

Acromegaly: pathogenesis, diagnosis, and management - ScienceDirect

Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region in: Endocrine-Related Cancer Volume 30 Issue 7 (2023)

Acromegaly: pathogenesis, diagnosis, and management - The Lancet Diabetes & Endocrinology

Frontiers Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future in: Endocrine-Related Cancer Volume 23 Issue 12 (2016)

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future in: Endocrine-Related Cancer Volume 23 Issue 12 (2016)